Molecular and Cellular Biology, October 1999, p. 6765-6774, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
G Alpha-q/11 Protein Plays a Key Role in
Insulin-Induced Glucose Transport in 3T3-L1 Adipocytes
Takeshi
Imamura,1
Peter
Vollenweider,1
Katsuya
Egawa,1
Martin
Clodi,1
Kenichi
Ishibashi,1
Naoki
Nakashima,1
Satoshi
Ugi,1
John W.
Adams,2
Joan Heller
Brown,2 and
Jerrold M.
Olefsky1,*
Department of Medicine, Division of
Endocrinology and Metabolism,1 and
Department of Pharmacology,2
University of California, San Diego, La Jolla, California 92093
Received 19 May 1999/Returned for modification 24 June
1999/Accepted 2 July 1999
 |
ABSTRACT |
We evaluated the role of the G alpha-q (G
q) subunit of
heterotrimeric G proteins in the insulin signaling pathway leading to
GLUT4 translocation. We inhibited endogenous G
q function by single
cell microinjection of anti-G
q/11 antibody or RGS2 protein (a GAP
protein for G
q), followed by immunostaining to assess GLUT4
translocation in 3T3-L1 adipocytes. G
q/11 antibody and RGS2
inhibited insulin-induced GLUT4 translocation by 60 or 75%, respectively, indicating that activated G
q is important for
insulin-induced glucose transport. We then assessed the effect of
overexpressing wild-type G
q (WT-G
q) or a constitutively active
G
q mutant (Q209L-G
q) by using an adenovirus expression vector. In
the basal state, Q209L-G
q expression stimulated
2-deoxy-D-glucose uptake and GLUT4 translocation to 70% of
the maximal insulin effect. This effect of Q209L-G
q was inhibited by
wortmannin, suggesting that it is phosphatidylinositol 3-kinase
(PI3-kinase) dependent. We further show that Q209L-G
q stimulates
PI3-kinase activity in p110
and p110
immunoprecipitates by 3- and
8-fold, respectively, whereas insulin stimulates this activity mostly
in p110
by 10-fold. Nevertheless, only microinjection of
anti-p110
(and not p110
) antibody inhibited both insulin- and
Q209L-G
q-induced GLUT4 translocation, suggesting that the metabolic
effects induced by Q209L-G
q are dependent on the p110
subunit of
PI3-kinase. In summary, (i) G
q appears to play a necessary role in
insulin-stimulated glucose transport, (ii) G
q action in the insulin
signaling pathway is upstream of and dependent upon PI3-kinase, and
(iii) G
q can transmit signals from the insulin receptor to the
p110
subunit of PI3-kinase, which leads to GLUT4 translocation.
 |
INTRODUCTION |
G-protein-coupled receptors (GPCRs)
are seven-transmembrane-domain-containing cell surface proteins which
activate heterotrimeric G proteins consisting of
and 
subunits. Ligand binding to GPCRs induces GDP-GTP exchange on the G
subunit, causing dissociation from the G
subunits
(18). G
, as well as the G
subunit complex, can
independently propagate a cascade of intracellular signaling events,
and it is clear that heterotrimeric G proteins have numerous biological
functions (4). Since there are several classes of G
,
G
, and G
subunits, it is still not clearly understood how the
different subunits mediate the large variety of biological effects of GPCRs.
Although heterotrimeric G proteins typically respond to GPCRs, cross
talk between receptor tyrosine kinases (RTKs) and GPCR signaling
pathways has recently been reported (27). Thus, insulin-like growth factor I mediates mitogen-activated protein kinase (MAPK) activation through a pathway that is, at least in part, G
i
dependent. GPCR stimulation of G proteins can also lead to mitogenic
signaling through MAPK activation (25). For example,
angiotensin II, which signals through G
q, stimulates MAPK activity
following Ras activation (21). On the other hand, there is
only limited information on any potential role for G proteins in
metabolic signaling, such as stimulation of glucose transport. It has
been reported that after bradykinin receptor overexpression, bradykinin
can stimulate glucose uptake into cells in a G
q-dependent manner
(12). Interestingly, G
q also mediates the
1-adrenergic effects of catecholamines, which are
counterregulatory to the effects of insulin, in part due to inhibition
of glucose uptake (13). These findings raise the possibility
that G
q modulates insulin signaling in target tissues.
Therefore, we have directly studies the involvement of G
q/11 in
insulin-stimulated glucose transport and insulin-responsive glucose
transporter (GLUT4) translocation. We show that in 3T3-L1 adipocytes,
endogenous G
q function is necessary for insulin-induced GLUT4
translocation and that a constitutively active G
q (Q209L-G
q) stimulates 2-deoxy-D-glucose (2-DOG) uptake and GLUT4
translocation in a phosphatidylinositol 3-kinase (PI3-kinase)-dependent
mechanism. Taken together, our results suggest a necessary role for
G
q in the metabolic signaling cascade leading from the insulin
receptor to PI3-kinase and glucose uptake.
 |
MATERIALS AND METHODS |
Materials.
Anti-IRS-1 and anti-phospho-specific Akt
antibodies were purchased from Upstate Biotechnology Inc. (Lake Placid,
N.Y.). Mouse monoclonal anti-GLUT4 antibody (1F8) was from Biogenesis
Inc. (Brentwood, N.H.), and rabbit polyclonal anti-GLUT4 antibody
(F349) was kindly provided by Michael Mueckler (Washington University, St. Louis, Mo.). Sodium azide-free monoclonal antiphosphotyrosine (PY-20) and protein kinase C-
(PKC-
) antibodies, and horseradish peroxidase-conjugated antiphosphotyrosine antibody (RC-20) were from
Transduction Laboratories (Lexington, Ky.). Horseradish
peroxidase-linked anti-rabbit, anti-mouse, and anti-goat antibodies and
anti-Akt1 and G
q/11, antibodies were from Santa Cruz Biotechnology
(Santa Cruz, Calif.). Sheep immunoglobulin G (IgG) and fluorescein
isothiocyanate (FITC)-, tetramethylrhodamine isothiocyanate (TRITC)-
and aminomethylcoumarin acetate-conjugated anti-rabbit, anti-mouse,
anti-goat, and anti-sheep IgG antibodies were from Jackson
Immunoresearch Laboratories Inc. (West Grove, Pa.). Wild-type and
GTPase-deficient (activated) Q209L mutant G
q expression vector and
recombinant adenoviruses have been described elsewhere (1).
The RGS2 expression vector was kindly provided by John R. Hepler
(Washington University). Dulbecco's modified Eagle's medium (DMEM)
and fetal calf serum (FCS) were purchased from Life Technologies (Grand
Island, N.Y.). All radioisotopes were from ICN (Costa Mesa, Calif.).
All other reagents were purchased from Sigma Chemical Co. (St. Louis,
Mo.).
Cell culture and microinjection.
3T3-L1 cells were cultured
and differentiated as previously described (8).
Microinjection of the various reagents was carried out with a
semiautomatic Eppendorf microinjection system. All reagents for
microinjection were dissolved in microinjection buffer consisting of 5 mM sodium phosphate (pH 7.2) and 100 mM KCl. Antibodies were coinjected
into the cytoplasm of the cell with 5 mg of sheep IgG per ml to allow
identification of injected cells. Expression vectors for the various
G
q proteins were directly injected into the nuclei of living cells,
and protein expression was allowed to continue for 24 h.
Cytomegalovirus-green fluorescent protein (GFP) expression vector was
coinjected for identification of injected cells in the nuclear
microinjection studies.
Immunostaining and immunofluorescence microscopy.
Immunostaining of GLUT4 was performed essentially as described
previously (26). The cells were fixed in 3.7% formaldehyde in phosphate-buffered saline (PBS) for 10 min at room temperature. After being washed, the cells were permeabilized and blocked with 0.1%
Triton X-100-2% FCS in PBS for 10 min. The cells were then incubated
with anti-GLUT4 antibody (1F8 or F349) in PBS-2% FCS overnight at
4°C. After the cells were washed, anti-GLUT4 and injected IgG were
detected by incubation with TRITC-conjugated donkey anti-mouse or
anti-rabbit IgG antibody and AMCA-conjugated donkey anti-sheep
antibody, respectively, followed by observation under an
immunofluorescence microscope.
For the membrane-ruffling staining, fixed cells were permeabilized with
0.1% Triton X-100 in PBS for 5 min. After being washed with PBS, the
cells were incubated with TRITC-conjugated phalloidin to visualize the
membrane ruffles and with FITC-conjugated donkey anti-rabbit antibody
to detect the injected IgG, as described previously (17).
In all counting experiments, the observer was blinded to the
experimental condition of each coverslip. For the nuclear
microinjection study, FITC-positive (GFP protein-expressing) cells were
evaluated for the presence of plasma membrane-associated GLUT4 staining.
Cell treatments.
3T3-L1 adipocytes were incubated with 300 nM wortmannin or 0.1% dimethyl sulfoxide vehicle for 1 h at
37°C after starvation.
For adenovirus infection, 3T3-L1 adipocytes were transduced at a
multiplicity of infection (MOI) of 10 PFU/cell for 16 h with either a control recombinant adenovirus containing a lacZ
gene or the recombinant adenoviruses wild-type G
q, Q209L mutant
G
q, or p110caax. Transduced cells were incubated for 60 h at
37°C under 10% CO2 in high-glucose DMEM with 2%
heat-inactivated FCS, followed by incubation in the starvation media
required for the assay. The efficiency of adenovirus-mediated gene
transfer was above 90% as measured by histocytochemical staining of
lacZ-infected cells with
-galactosidase, as we reported
previously (22). The survival of the differentiated 3T3-L1
adipocytes was unaffected by incubation of cells with the different
adenovirus constructs, since the total amount of cell protein remained
the same in infected and uninfected cells.
Western blotting.
3T3-L1 adipocytes were starved for 12 hrs
in regular glucose DMEM plus with 0.1% bovine serum albumin. The cells
were stimulated with 100 ng of insulin per ml for 10 or 30 min at
37°C and lysed for 30 min at 4°C in a solubilizing buffer
containing 20 mM Tris, 1 mM EDTA, 140 mM NaCl, 1% Nonidet P-40, 50 U
of aprotinin/ml, 1 mM Na3VO4, 1 mM
phenylmethylsulfonyl fluoride, and 1 mM NaF (pH 7.5). The cell lysates
were centrifuged to remove insoluble materials. For Western blot
analysis, whole-cell lysates (30 to 80 µg of protein per lane) were
denatured by boiling in Laemmli sample buffer containing 100 mM
dithiothreitol and resolved by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). Gels were transferred to polyvinylidene
difluoride membrane (Immobilon-P; Millipore, Bedford, Mass.) by using a
Transblot apparatus (Bio-Rad, Hercules, Calif.). For immunoblotting,
the membranes were blocked and probed with specified antibodies. The
blots were then incubated with horseradish peroxidase-linked second
antibody followed by chemiluminescence detection, as specified by the
manufacturer (Pierce Chemical Co., Rockford, Ill.).
PI3-kinase assay.
After 60 h of adenovirus infections,
serum-starved (for 12 h) 3T3-L1 adipocytes were incubated in the
absence (basal) or presence of insulin (100 ng/ml) for 10 min or
platelet-derived growth factor (PDGF) (100 ng/ml) for 2 min, washed
once with ice-cold PBS, lysed, and subjected to immunoprecipitation
(300 to 500 mg of total protein) with anti-p110
or anti-p110
antibody (2 µg) for 4 h at 4°C. Immunocomplexes were
precipitated from the supernatant with protein G plus agarose (Santa
Cruz Biotechnology) and washed as described previously (23). The washed
immunocomplexes were incubated with phosphatidylinositol plus
[
-32P]ATP (3,000 Ci/mmol) for 10 min at room
temperature. The reactions were stopped with 20 µl of 8 N HCl, the
reaction mixtures were mixed with 160 µl of
CHCl3-methanol (1:1) and centrifuged, and the lower
(organic) phase was removed and applied to a silica gel thin-layer
chromatography plate which had been coated with 1% potassium oxalate.
The thin-layer chromatography plates were developed in
CHCl3-CH3OH-H2O-NH4OH
(60:47:11.3:2), dried, and visualized, and quantitated on a
PhosphorImager (Molecular Dynamics).
2-Deoxyglucose uptake.
The procedure for glucose uptake was
a modification of the methods described by Klip et al. (14).
After 60 h of adenovirus infections, serum- and glucose-deprived
3T3-L1 adipocytes were incubated in alpha MEM in the absence (basal) or
presence of 100 ng of insulin per ml for 1 h at 37°C. Glucose
uptake was determined in duplicate or triplicate at each point after
the addition of 10 µl of substrate (0.1 µCi of
2-[3H]deoxyglucose or
L-[3H]glucose; final concentration, 0.01 mmol/liter) to provide a concentration at which cell membrane transport
was rate limiting. The value for L-glucose was subtracted
to correct each sample for the contributions of diffusion and trapping.
 |
RESULTS |
Effect of endogenous G
q on insulin-induced GLUT4 translocation
in 3T3-L1 adipocytes.
G
q protein is distributed in many
tissues, including 3T3-L1 adipocytes (see Fig. 2A, lanes a to d).
Insulin induces glucose uptake by promoting the translocation of GLUT4
proteins from an intracellular pool to the cell surface in adipocytes
and myocytes (20). We have assessed the role of endogenous
G
q on insulin stimulated-GLUT4 translocation in 3T3-L1 adipocytes by
using microinjection of anti-G
q/11 antibody or purified RGS2
protein, which is a specific G
q GAP protein (10). For the
quantitative detection of GLUT4 translocation, we used
immunofluorescent staining of GLUT4 with specific antibodies
(8). In the basal state, cells display GLUT4 staining mostly
in a perinuclear localization, with some staining distributed in the
cytoplasm (Fig. 1A, panel a); after insulin stimulation, GLUT4 staining is seen at the plasma membrane as a
circumferential ring, with a concomitant decrease in intracellular distribution (Fig. 1A, panel b), as previously described
(26). As shown in Fig. 1B, single-cell microinjection of
G
q/11 antibody or RGS2 protein into 3T3-L1 adipocytes markedly
inhibited (70 and 81%, respectively) insulin induced-GLUT4
translocation. These findings suggest that activated G
q plays a
necessary role in the insulin signaling cascade leading to GLUT4
translocation.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 1.
Effects of anti-G q antibody or RGS2 protein
microinjection on insulin-induced GLUT4 translocation in 3T3-L1
adipocytes. Serum-starved 3T3-L1 adipocytes on coverslips were
incubated with or without insulin (4 and 10 ng/ml) for 20 min after the
microinjection of sheep IgG, anti-G q/11 antibody, or RGS2 protein,
mixed with sheep IgG as a marker, as described in Materials and
Methods. (A) Representative cells of GLUT4 staining are shown in the
top panels (a to d), and staining of injected RGS2/sheep IgG (c and d)
or sheep IgG alone (a and b) is shown in the bottom panels. (B)
Percentage of cells positive for GLUT4 translocation, calculated by
counting at least 100 cells at each point. Injected materials are sheep
IgG for Control, anti-G q/11 C-terminal antibody for Gq-Ab, and RGS2
protein mixed with sheep IgG for RGS2. The data are means and standard
errors from four independent experiments.
|
|
Effect of a constitutively active G
q mutant on glucose transport
in 3T3-L1 adipocytes.
To further explore the functional importance
of activated G
q in insulin induced-glucose transport in 3T3-L1
adipocytes, we used recombinant adenovirus vectors containing either
wild-type (WT) or a constitutively active mutant (Q209L) G
q cDNA. To
demonstrate G
q protein expression in 3T3-L1 adipocytes after
infection with these adenovirus vectors, we performed Western blotting
on whole-cell lysates with an anti-G
q/11 antibody directed against
the C terminus of the protein. As shown in Fig.
2A, G
q protein expression was proportional to the G
q adenovirus concentration (MOI). Infection with both WT and mutant Q209L-G
q adenoviruses at an MOI of 10 (Fig.
2A, top, lanes g and k) increased the intensity of the 42-kDa band
(corresponding to G
q protein) 10-fold compared with infection by
mock control adenovirus at an MOI of 10 (lane c). On the other hand,
there was almost no change in the amount of G
subunit (
1-5) expression after 60 h of G
q adenovirus infection (Fig. 2A,
bottom). These results show that G
q adenovirus transfection results
in increased G
q protein levels that are not accompanied by increased G
-subunit expression.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 2.
Expression and effects of G q on glucose uptake into
the 3T3-L1 adipocytes. (A) Differentiated 3T3-L1 adipocytes were
infected with various concentrations (MOI = 1, 5, 10, and 20) of
adenovirus expressing WT G q, Q209L-G q, or mock-infected control.
After 60 h of infection, these cells were lysed, and total-cell
lysates were analyzed by Western blotting with anti-G q/11 C-terminal
antibody (top) or anti-G 1-5 antibody (bottom), as
described in Materials and Methods. These experiments were repeated
twice. (B) 3T3-L1 adipocytes were infected with various concentrations
(MOI = 1, 5, 10, 20, 30, and 40) of adenovirus expressing WT
G q, Q209L-G q, or mock control. After 60 h of infection,
these cells were stimulated with 100 ng of insulin per ml for 1 h
and 2-[3H]deoxyglucose uptake was measured as described
in Materials and Methods. The data are the means and standard errors
from four independent experiments.
|
|
We next assessed the effects of WT and Q209L-G
q expression on
insulin-induced 2-DOG uptake (Fig. 2B). Increasing concentrations of
control- or WT-expressing adenovirus had no effect on basal or
insulin-stimulated 2-DOG uptake compared to that in mock-transfected cells (Fig. 2B). In contrast, Q209L-G
q increased basal 2-DOG uptake
to 80% of the effect of insulin in a dose-dependent manner. At
intermediate MOIs of 20 and 30, which led to substantial stimulation of
glucose transport, the effects of subsequent addition of insulin were
somewhat reduced.
The effects of constitutively active G
q on GLUT4 translocation were
comparable to its effects on glucose transport. Thus, as shown in Fig.
3A, insulin (10 ng/ml) led to a fourfold
stimulation of GLUT4 translocation in control cells. WT G
q
expression had no effect on either basal or insulin-induced GLUT4
translocation. On the other hand, Q209L-G
q expression increased
basal GLUT4 translocation by 2.2-fold to 39%. Addition of insulin to
Q209L-G
q-expressing cells led to minimal further stimulation.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of G q expression on insulin-induced GLUT4
translocation in 3T3-L1 adipocytes. Serum-starved 3T3-L1 adipocytes on
coverslips were incubated with or without insulin (10 ng/ml) for 20 min
after 60 h of G q-expressing adenovirus infection (MOI = 10) (A) or after 24 h of nuclear microinjection with G q
expression vector and with GFP expression vector as a marker (B). Fixed
cells were stained with rabbit anti-GLUT4 antibody and incubated with
TRITC-conjugated anti-rabbit IgG antibody, as described in Materials
and Methods. The percentage of cells positive for GLUT4 translocation
was calculated by counting at least 100 cells at each point. The data
are means and standard errors from three independent experiments. (A)
Cont., mock control adenovirus; Q209L, Q209L-G q-expressing
adenovirus; WT, wild-type-G q-expressing adenovirus. (B) Control
vector, GFP-expressing vector only.
|
|
To confirm the effects of overexpressed G
q protein independent of
adenovirus infection, we microinjected the expression vectors containing the G
q cDNA directly into the nucleus of living 3T3-L1 adipocytes and then assessed their acute effects on GLUT4 translocation by using previously described methods (26). Vectors for WT
and Q209L-G
q (0.1 mg/ml) were microinjected into the nucleus of
3T3-L1 adipocytes, along with a vector for GFP, to allow the detection of injected cells. Cells positive for GFP expression (detected by FITC
fluorescence) were analyzed for GLUT4 translocation. As shown in Fig.
3B, expression of WT G
q had no effect on basal or insulin-induced
GLUT4 translocation compared to the control (GFP expression alone).
Expression of Q209L-G
q increased basal GLUT4 translocation by
1.7-fold and inhibited insulin-induced (10 ng/ml) GLUT4 translocation.
These results are comparable to those observed after
adenovirus-mediated WT and Q209L-G
q expression (Fig. 3A).
Mechanisms of G
q signaling to glucose transport.
After
ligand binding to GPCRs, G
subunits dissociate from the G
subunit and can mediate biologic signals (4). To determine whether G
subunits were involved in glucose transport signaling, we used a glutathione S-transferase (GST) fusion protein
containing the C-terminal portion of the
-adrenergic receptor kinase
(GST-BARK). This protein binds to G
subunits and behaves as a
dominant negative inhibitor of G
signaling (7). We
therefore microinjected GST-BARK into the cytoplasm of cells infected
with WT or Q209L-G
q adenovirus and measured insulin-stimulated GLUT4
translocation. As shown in Fig. 4A,
GST-BARK had no effect on basal, insulin-stimulated, or
Q209L-G
q-stimulated GLUT4 translocation. As a control, we demonstrated the functional integrity of GST-BARK, by showing that it
inhibited lysophosphatidic acid- and thrombin-stimulated DNA synthesis
when microinjected into HIRc cells (data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
Microinjection and treatments of inhibitors and p110caax
expression on G q expressed 3T3-L1 adipocytes. (A) After 60 h of
G q-expressing adenovirus infection (MOI = 10), 3T3-L1 cells
were injected with antiphosphotyrosine antibody (PY-20), GST-BARK, or
sheep IgG as a control, prior to 3 h of insulin stimulation. Fixed
cells were stained with rabbit anti-GLUT4 antibody and incubated with
TRITC-conjugated anti-rabbit IgG antibody and AMCA-conjugated
anti-sheep IgG antibody, as described in Materials and Methods. (B)
After 60 h of G q-expressing adenovirus infection (MOI = 10) with or without p110caax-expressing adenovirus coinfection (CAAX),
3T3-L1 adipocytes were incubated with 300 nM wortmannin (Wort) or 0.1%
DMSO vehicle for 60 min and with insulin (100 ng/ml) for 50 min or left
untreated. 2-[3H]deoxyglucose uptake was measured as
described in Materials and Methods. The data are means and standard
errors from three independent experiments.
|
|
To determine whether the effect of Q209L-G
q on GLUT4 translocation
was dependent on downstream tyrosine phosphorylation, we microinjected
antiphosphotyrosine antibodies (PY-20) into control and WT- and
Q209L-G
q-infected cells. Although PY-20 antibody inhibited insulin
stimulated GLUT4 translocation, it had no effect on the action of
Q209L-G
q. Interestingly, neither BARK nor PY-20 prevented the effect
of Q209L-G
q from inhibiting the effects of insulin on GLUT4
translocation (Fig. 4A).
Insulin-stimulated glucose transport is PI3-kinase dependent, and
therefore, to evaluate the role of PI3-kinase in the action of G
q on
glucose transport, we used several approaches. We found that the
PI3-kinase inhibitor wortmannin blocked insulin- and Q209L-G
q-stimulated glucose transport and GLUT4 translocation (Fig.
4B). p110caax is a membrane-targeted, constitutively active form of the
p110
subunit of PI3-kinase, and we have previously shown that
adenovirus-mediated expression of this protein in 3T3-L1 adipocytes is
sufficient to stimulate GLUT4 translocation and glucose transport
(6). As seen in Fig. 4B and 5,
p110caax stimulates GLUT4 translocation and glucose transport to
approximately the same magnitude, as does insulin. Importantly,
however, while microinjection of the anti-G
q/11 antibody blocks
insulin action, it is without effect on the stimulatory effects of
p110caax (Fig. 5). Taken together, these findings demonstrate that the
effects of Q209L-G
q are PI3-kinase dependent, indicating that G
q
lies upstream of PI3-kinase in the insulin signaling pathway.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of G q antibody microinjection on GTP S and
p110caax signaling to GLUT4 translocation. 3T3-L1 cells infected with
or without p110caax-expressing adenovirus were injected with
anti-G q/11 antibody or sheep IgG with or without GTP S. After
1 h, the cells were stimulated with insulin or left unstimulated,
and then fixed. Fixed cells were stained with rabbit anti-GLUT4
antibody and incubated with TRITC-conjugated anti-rabbit IgG antibody
and AMCA-conjugated anti-sheep IgG antibody as described in Materials
and Methods.
|
|
We have previously shown that when microinjected or electroporated into
3T3-L1 adipocytes, GTP
S stimulates GLUT4 translocation in a
PI3-kinase independent manner (9). Along these lines, Fig. 5
demonstrates that microinjection of anti-G
q/11 antibody does not
inhibit GTP
S-stimulated GLUT4 translocation, and this is consistent
with the view that the locus of G
q in the insulin signaling cascade
is upstream of PI3-kinase.
The effect of Q209L-G
q on glucose transport depends on the
p110
subunit of PI3-kinase.
To further explore the role of
PI3-kinase in G
q action, we assessed PI3-kinase activity in
anti-p110
or anti-p110
antibody immunoprecipitates. As shown in
Fig. 6A, PI3-kinase activity in anti-p110
immunoprecipitates was modestly increased (threefold) in
Q209L-G
q expressing cells compared to controls. In contrast, insulin
led to a much larger stimulation of p110
activity in both control
and WT-G
q-expressing cells. Interestingly, the effect of insulin on
increasing p110
activity was modestly blunted in the Q209L-G
q
expressing cells, although the effect of PDGF on p110
activity was
unimpaired. In contrast to the p110
results, p110
activity was
markedly stimulated (fivefold) by Q209L-G
q whereas insulin had only
a small effect on p110
activity (Fig. 6B).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 6.
PI3-kinase activities of p110 and p110 subunit in
3T3-L1 adipocytes after G q expression. Serum-starved 3T3-L1
adipocytes were incubated in the absence or presence of insulin (100 ng/ml) for 10 min or PDGF (50 nM) for 2 min, after 60 h of
G q-expressing adenovirus infection. Cell lysates were
immunoprecipitated (IP) with anti-p110 or anti-p110 antibody, and
immune complexes were assayed for their ability to phosphorylate
phosphatidylinositol. Reaction products (phosphatidylinositol-3
phosphate) were analyzed by thin-layer chromatography, and signals were
quantitated on a PhosphorImager, as described in Materials and Methods.
The data are means and standard errors from three independent
experiments. (A) p110 PI3-kinase activity; (B) p110 PI3-kinase
activity. Cont., control.
|
|
To determine the functional role of the different p110 subunits in
insulin- and Q209L-G
q-induced signaling to glucose transport, we
examined GLUT4 translocation following microinjection of antibodies against the C terminus of the p110
or p110
catalytic domains. As
seen in Fig. 7A, the anti-p110
antibody blocked both Q209L-G
q- and insulin-stimulated GLUT4
translocation whereas anti-p110
antibody had no inhibitory effects.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 7.
Role of PI3-kinase in insulin-induced GLUT4
translocation in G q expressed 3T3-L1 adipocytes. After 60 h of
G q-expressing adenovirus infection (MOI = 10), 3T3-L1 cells
were injected with anti-p110 , anti-p110 , or sheep IgG as a
control (Cont). After insulin stimulation, fixed cells were stained
with rabbit anti-GLUT4 antibody and incubated with TRITC-conjugated
anti-rabbit IgG antibody and FITC-conjugated anti-goat or anti-sheep
IgG antibody, as described in Materials and Methods. The data are means
and standard errors from three independent experiments.
|
|
We have previously demonstrated that insulin has a robust effect on the
stimulation of membrane ruffling in 3T3-L1 adipocytes and that this
effect is dependent on PI3-kinase activation, since it is inhibitable
by wortmannin (17). In the present studies, we have examined
the role of G
q in the insulin signaling cascade leading to membrane
ruffling. As seen in Fig. 8,
microinjection of the anti-p110
antibody inhibited insulin-induced
membrane ruffling, consistent with the PI3-kinase dependency of this
biological effect. Importantly, however, microinjection of
anti-G
q/11 antibody or the RGS2 protein did not affect
insulin-stimulated membrane ruffling, although injection of these
reagents inhibited insulin-stimulated GLUT4 translocation (Fig. 8) and
the effect of Q209L-G
q was dependent on p110
. Taken together,
these results indicate that insulin-stimulated GLUT4 translocation and
membrane ruffling are both dependent on PI3-kinase activity but that
insulin-directed G
q stimulation of PI3-kinase is specifically
targeted to the glucose transport stimulatory pathway.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 8.
Effects of G q on insulin-induced membrane ruffling in
3T3-L1 adipocytes. 3T3-L1 cells were microinjected with anti-G q/11,
anti-p110 antibody, RGS2 protein with sheep IgG, or sheep IgG as a
control. After insulin stimulation, fixed cells were stained with
rhodamine-phalloidin and FITC-conjugated anti-goat, anti-sheep, or
anti-rabbit IgG antibody, as described in Materials and Methods. The
data are means and standard errors from three independent
experiments.
|
|
To further assess the mechanisms of G
q stimulation of PI3-kinase, we
investigated whether endogenous G
q directly interacts with the
p110
subunit of PI3-kinase. p110
was observed in the anti-G
q/11 C-terminal antibody immunoprecipitates from basal cells,
and the amount of coprecipitated p110
increased markedly after
insulin stimulation (Fig. 9A). IRS-1 was
not detected in the immunoprecipitates with anti-G
q antibody (data
not shown). Importantly, G
q/11 protein was immunoprecipitated with
anti-insulin receptor
-subunit antibody, and the intensity of the
bands was not changed by insulin stimulation (Fig. 9A).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 9.
G q activity and association of G q with insulin
receptor -subunit and p110 subunit of PI3-kinase. 3T3-L1
adipocytes were lysed and immunoprecipitated (IP) with anti-G q/11 or
IR- antibodies. Immunoprecipitates were analyzed by Western blotting
with anti-p110 antibody (A, top), anti-G q/11 antibody (A, middle
and bottom panel), or PY-20 antibody (B). These experiments were
repeated twice.
|
|
Tyrosine phosphorylation of G
q/11.
Since it has been
reported that a tyrosine residue in the C terminus of G
q/11 becomes
phosphorylated after GPCR stimulation, we determined whether G
q/11
tyrosine phosphorylation was enhanced by insulin treatment
(24). Cells were stimulated with insulin for various periods
and then subjected to followed by phosphotyrosine blotting of G
q/11
immunoprecipitates. As can be seen in Fig. 9B, insulin treatment led to
a rapid, large, and transient increase in tyrosine phosphorylation of
G
q/11. Since earlier studies have shown that activation of G
q/11
correlates with tyrosine phosphorylation, these data suggest that
insulin can lead to G
q/11 activation.
Specificity of G
q for insulin-stimulated glucose transport.
To further demonstrate the specificity of G
q stimulation for the
glucose transport pathway, we measured several other aspects of insulin
action. As seen in Fig. 10, insulin
stimulates MAPK and p70S6K phosphorylation whereas the effects of
Q209L-G
q expression are negligible. Akt activation involves
serine/threonine phosphorylation, and this can be determined with a
phospho-specific Akt antibody or by assessing the Akt gel shift with
anti-Akt antibodies. As Fig. 11B
demonstrates, insulin causes a robust stimulation of Akt phosphorylation and an Akt gel-shift in control and WT-G
q-infected cells. In contrast, expression of Q209L-G
q causes only a minimal stimulation of Akt phosphorylation, and no detectable Akt gel shift,
consistent with the fact that Q209L-G
q leads to only a modest
stimulation of p110
(Fig. 6A). Interestingly, the effect of insulin
on further stimulating Akt was impaired and the effect on p70S6K
phosphorylation was modestly inhibited in Q209L-G
q-expressing cells.
In contrast, PDGF stimulation of Akt was unaffected by Q209L-G
q
expression.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 10.
Effects of Q209L-Gq on MAPK or p70S6-kinase activities
in 3T3-L1 adipocytes. Serum-starved 3T3-L1 adipocytes were incubated in
the absence or presence of insulin (100 ng/ml) for 10 min, after
60 h of G q-expressing adenovirus infection. Whole-cell lysates
were subjected to SDS-PAGE and immunoblotted with phosphospecific MAPK
antibody (A) or phosphospecific p70S6K antibody (B), as described in
Materials and Methods. These experiments were repeated twice.
|
|

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 11.
Effects of anti-Akt or PKC- antibody injection on
GLUT4 translocation in 3T3-L1 adipocytes. (A) After 60 h of
G q-expressing adenovirus infection (MOI = 10), 3T3-L1 cells
were injected with anti-Akt antibody (Akt-Ab), PKC- antibody (PKC
-Ab), or sheep IgG as a control. After insulin stimulation, fixed
cells were stained with rabbit anti-GLUT4 antibody and incubated with
TRITC-conjugated anti-rabbit IgG antibody and FITC-conjugated
anti-mouse or anti-sheep IgG antibody. The data are means and standard
errors from three independent experiments. (B) Serum-starved 3T3-L1
adipocytes were incubated in the absence or presence of insulin (100 ng/ml) or PDGF (50 nM) for 10 min after 60 h of G q-expressing
adenovirus infection. Whole-cell lysates were subjected to SDS-PAGE and
immunoblotted with phosphospecific Akt antibody (top) or Akt antibody
(bottom) for the gel shift assay, as described in Materials and
Methods. These experiments were repeated twice.
|
|
Role of PKC-
and PKB/Akt in G
q actions.
The
serine/threonine kinase Akt, as well as atypical PKC isoforms, are
activated by PI3-kinase, and evidence that either or both may be
involved in insulin-stimulated glucose uptake exists (15,
16). To assess this, we microinjected anti-Akt or PKC-
antibodies into 3T3-L1 adipocytes in the basal and insulin-stimulated states in control and Q209L-G
q-expressing cells. Both insulin- and
Q209L-G
q-induced GLUT4 translocation were completely inhibited by
anti-PKC-
antibody injection, whereas anti-PKB/Akt antibody was
without effect (Fig. 11A).
 |
DISCUSSION |
The ability of insulin to stimulate glucose transport is one of
its most important physiologic actions. However, despite intense study,
the signaling pathway mediating this biologic effect remains poorly
understood. Although a number of molecular components have been
proposed as participants in these signaling events, little consensus
exists. Despite these uncertainties, there is relatively uniform
agreement that activation of PI3-kinase is a necessary event, which
participates in connecting the insulin receptor to stimulation of
glucose transport (19). The major findings of the current
studies are that heterotrimeric G proteins are important components of
this insulin action pathway. Specifically, we found that G
q/11 is
necessary for insulin-stimulated glucose transport and that this
molecule can be tyrosine phosphorylated by the insulin receptor and
forms a molecular complex with the p110
-subunit of PI3-kinase which
leads to glucose transport stimulation.
Since the initial discovery of insulin receptor substrate type 1 (IRS-1), numerous studies have demonstrated that IRS-1 and its other
family members are bona fide substrates of the insulin receptor which
become tyrosine phosphorylated and then bind to the p85 subunit of
PI3-kinase, leading to PI3-kinase activation and downstream signaling
(2, 22). Although IRS proteins are obviously candidates
connecting the insulin receptor to PI3-kinase in the signaling pathway
leading to glucose transport stimulation, we and others have provided
previous data showing that these proteins are not necessary for
insulin-stimulated glucose transport, indicating either that IRS
proteins are not important components of glucose transport stimulation
or that alternate pathways linking the insulin receptor to PI3-kinase
exist (23). Thus, since PI3-kinase activation is an absolute
requirement for glucose transport stimulation whereas IRS-1 is not,
some other mechanism connecting the insulin receptor to PI3-kinase
stimulation must exist.
Traditionally, GPCRs and receptor tyrosine kinase (RTK) signaling
pathways have been viewed as distinct and nonoverlapping. However,
recent evidence from several different systems has indicated overlap
and convergence between RTK and GPCR signaling mechanisms (5,
25), since both pathways engage many of the same molecules and
since GPCR stimulation can lead to tyrosine phosphorylation events and
certain RTK signaling events are G-protein dependent. In the present
studies, we have found that the ability of insulin to stimulate glucose
transport is dependent on the function of a heterotrimeric G protein
containing G
q. Thus, microinjection of anti-G
q/11 antibody into
3T3-L1 adipocytes markedly inhibits the ability of insulin to stimulate
GLUT4 translocation. Like all G proteins, G
q is active in the
GTP-bound state and inactive when bound to GDP (25). RGS2 is
a specific G
q GAP protein which hydrolyzes G
q bound GTP to GDP
(10). Thus, the RGS2 protein will specifically inhibit
normally activated G
q, and when the RGS2 protein was microinjected
into 3T3-L1 adipocytes, insulin-stimulated GLUT4 translocation was abrogated.
The inhibition of GLUT4 translocation by anti-G
q/11 antibody and
RGS2 protein was highly specific for the insulin-stimulated response,
since microinjection of these inhibitory reagents had no effect on
GTP
S-stimulated or p110caax-stimulated GLUT4 translocation. These
results indicate that the anti-G
q/11 antibody does not inhibit
insulin-stimulated glucose transport nonspecifically and also indicate
that the site of G
q action in the insulin signaling pathway is
proximal to PI3-kinase action. Furthermore, we have previously shown
that in 3T3-L1 adipocytes, insulin has a robust effect on stimulation
of membrane ruffling in a PI3-kinase-dependent manner. Interestingly,
inhibition of G
q function has no effect on insulin-stimulated
membrane ruffling. Thus, we have measured two PI3-kinase-dependent
biologic effects in 3T3-L1 adipocytes, GLUT4 translocation and membrane
ruffling, and found that only GLUT4 translocation is blocked by
inhibition of G
q function. This suggests that G
q directs the
insulin signal fairly specifically to glucose transport stimulation.
In complementary experiments, we have used adenovirus gene transfer to
introduce a constitutively active form of G
q (Q209L-G
q) into
3T3-L1 adipocytes. The results demonstrate that Q209L-G
q leads to
GLUT4 translocation and stimulation of glucose transport with 60 to
70% effectiveness compared to insulin. The effects of Q209L-G
q on
stimulation of glucose transport are also specific, in that they do not
lead to global activation of all the insulin action pathways. For
example, Q209L-G
q does not stimulate membrane ruffling and has a
weak or undetectable effect on PKB/Akt, p70-S6 kinase, or MAPK
activation. The stimulatory effects of Q209L-G
q were strongly
blocked by coincubation with the PI3-kinase inhibitor wortmannin,
indicating that the action of G
q on stimulating glucose transport is
proximal to and dependent on PI3-kinase. Thus, consistent with the
microinjection studies, constitutively active G
q displays specificity for stimulation of the glucose transport-stimulatory pathway. Microinjection of an antiphosphotyrosine antibody (PY-20) inhibits insulin-stimulated but not Q209L-G
q-stimulated GLUT4 translocation, indicating that tyrosine phosphorylation events do not
lie downstream of the site of action of G
q, and this is also
consistent with the findings that expression of Q209L-G
q did not
lead to tyrosine phosphorylation of either the insulin receptor or
IRS-1 (data not shown). With respect to PI3-kinase, our results by no
means exclude the possibility that PI3-kinase plays a role in
facilitating downstream events in GLUT4 vesicle recruitment, such as
vesicle cycling and fusion. In this event, PI3-kinase could also be
parallel to G
q/11 in the insulin signaling pathway.
An interesting observation in our studies is that some of the measured
biologic effects of insulin were blunted in Q209L-G
q-expressing cells. Thus, the effect of insulin on stimulation of PI3-kinase and Akt
activity was reduced in Q209L-Gq-expressing cells, and these additive
effects of insulin on stimulation of glucose transport were slightly
and variably decreased. Since, in the adenovirus system, cells are
exposed to constitutively active G
q for 60 h prior to the
assay, our results are consistent with other models of cellular insulin
resistance. Thus, osmotic shock (3) and chronic exposure to
constitutively active PI3-kinase (6) both cause glucose
transport stimulation and both render cells relatively refractory to
subsequent insulin stimulation. Indeed, it is well recognized that
chronic insulin treatment will induce a state of cellular insulin
resistance. This is consistent with the view that chronically
stimulating the insulin action pathway will lead to desensitization of
the pathway at one or more steps. Although our results do not identify
the exact site of desensitization in Q209L-G
q-expressing cells, our
results do show that the insulin resistance is not global. Thus, the
ability of insulin to stimulate PI3-kinase and Akt activity were
inhibited whereas the effects of PDGF on these activities were
unchanged. Furthermore, not all of the actions of insulin were
inhibited, since stimulation of MAPK was normal. Clearly, further
studies to precisely elucidate the molecular cause of the insulin
resistance in this system should be performed.
The above-described studies clearly demonstrate the necessity for G
q
in the signaling pathway leading to insulin-stimulated glucose
transport and show that the effects of G
q are proximal to, and
dependent on, PI3-kinase. Additionally, our results have further
explored the mechanisms whereby G
q interacts with PI3-kinase. Thus,
we show that G
q has a large effect on stimulation of the PI3-kinase
activity of the p110
subunit but only a modest effect on stimulation
of p110
. On the other hand, insulin has a large effect on
stimulation of p110
and only a small effect on stimulation of
p110
. However, upon microinjecting both p110
and p110
antibodies into 3T3-L1 adipocytes, we found that the p110
antibody
blocked the effects of both insulin and Q209L-G
q on stimulation of
GLUT4 translocation whereas the p110
antibody was without effect.
These results indicate that under the direction of insulin, G
q
stimulates the p110
subunit of PI3-kinase, which then leads to
glucose transport stimulation. It is interesting that Q209L-G
q has
only a modest effect on p110
activity, compared to its robust effect
on p110
. This suggests that only a small degree of p110
stimulation is sufficient for transport activation and that proper
subcellular localization of the p110
activity is more important than
the total intracellular levels of this activated enzyme. From these findings, we suggest that G
q is an insulin receptor-directed targeting molecule which localizes active p110
to the correct intracellular compartment, where the distal events of transport signaling occur.
Our studies also provide insight as to how G
q is engaged by the
insulin signaling pathway. Thus, we find that G
q/11 coprecipitates with the p110
subunit and that following insulin stimulation, more
activated p110
is associated with G
q/11. G
q/11 also physically associates with the insulin receptor, since it can be identified in a
molecular complex with the insulin receptor in immunoprecipitation experiments. Interestingly, stimulation with insulin did not alter the
amount of insulin receptor-associated G
q/11. Previous reports have
demonstrated a tyrosine phosphorylation site in the G
q/11 C
terminus, and activation of G
q/11 is associated with phosphorylarion of this residue (24). Importantly, we found that insulin
stimulation leads to a marked increase in tyrosine phosphorylation of
G
q/11, consistent with the view that insulin leads to tyrosine
phosphorylation and activation of G
q/11, which then signals
downstream through the p110
subunit of PI3-kinase. This conclusion
is fortified by the fact that microinjection of the RGS2 protein, which
would only inhibit activated G
q/11, blocks insulin-stimulated GLUT4 translocation.
The molecular events downstream of PI3-kinase, which cause glucose
transport stimulation, have also been extensively studied. Akt and
PKC-
are serine kinases activated through the action of PI3-kinase,
and both have been suggested as mediators of glucose transport
stimulation (15, 16). To assess this in our system, we
microinjected anti-PKC-
and Akt antibodies into insulin-stimulated, as well as Q209L-G
q-expressing, 3T3-L1 adipocytes. The PKC-
antibody inhibited both insulin- and Q209L-G
q stimulated GLUT4 translocation, whereas the Akt antibody had no inhibitory effect. These
results certainly implicate PKC-
as a downstream mediator of glucose
transport stimulatory events, consistent with the recent work of Kotani
et al. (16). With respect to PKB/Akt, there are a number of
papers reporting both positive and negative evidence for its role in
glucose transport stimulation (11, 15). Our Akt antibody
injection results would argue against a role for Akt in this pathway;
however, these data are by no means conclusive, since they are
negative, and a positive effect of the antibody is not measurable in a
single cell microinjection system. Nevertheless, it is interesting that
although Q209L-G
q has a substantial effect on the stimulation of
GLUT4 translocation, it has a very negligible effect on the stimulation
of PKB/Akt phosphorylation. This is consistent with the antibody
injection findings, and, taken together, these results suggest that Akt
may not be a major downstream effecter of glucose transport stimulation
in our model system.
 |
ACKNOWLEDGMENTS |
This work was supported in part by NIH grant DK-33651 and the
V.A. Medical Research Service. Takeshi Imamura is supported through an
ADA Mentor Board Fellowship Award. Peter Vollenweider was supported by
a grant from the Schweizerische Stiftung fur Medizinisch-Biologische
Stipendien, and Martin Clodi was supported by grants J01287-Med and
J1584-Med from the Ewin Schrödinger Stipendium by the Austrian
Fonds zur Förderany der Wissenschaftlichen Forschung.
We thank John R. Hepler (Washington University, St. Louis, Mo.) for
providing the RGS2 expression vector, David W. Rose (University of
California, San Diego, La Jolla, Calif.) for technical assistance with
microinjection, and Elizabeth Hansen and Augustus P. Lestick for
editorial assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dept. of
Medicine (0673), University of California, San Diego, 9500 Gilman Dr.,
La Jolla, CA 92093. Phone: (858) 534-6651. Fax: (858) 534-6653. E-mail: jolefsky{at}ucsd.edu.
 |
REFERENCES |
| 1.
|
Adams, J. W.,
Y. Sakata,
M. G. Davis,
V. P. Sah,
Y. Wang,
S. B. Liggett,
K. R. Chien, and J. H. Brown.
1998.
Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.
Proc. Natl. Acad. Sci. USA
95:10140-10145[Abstract/Free Full Text].
|
| 2.
|
Araki, E.,
M. A. Lipes,
M. E. Patti,
J. C. Brüning,
B. Haag,
R. S. Johnson, and C. R. Kahn.
1994.
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
Nature
372:186-190[Medline].
|
| 3.
|
Chen, D.,
J. S. Elmendorf,
A. L. Olson,
X. Li, and H. S. Earp.
1999.
Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway.
J. Biol. Chem.
274:27401-27410.
|
| 4.
|
Clapham, D. E., and E. J. Neer.
1997.
G protein beta gamma subunits.
Annu. Rev. Pharmacol. Toxicol.
37:167-203[Medline].
|
| 5.
|
Daub, H.,
C. Wallasch, and A. Ullrich.
1996.
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.
Nature
379:557-560[Medline].
|
| 6.
|
Egawa, K.,
P. M. Sharma,
N. Nakashima,
Y. Huang,
E. Huver,
G. R. Boss, and J. M. Olefsky.
1999.
Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance.
J. Biol. Chem.
274:14306-14314[Abstract/Free Full Text].
|
| 7.
|
Garcia-Higuera, I., and F. Mayor, Jr.
1994.
Rapid desensitization of neonatal rat liver beta-adrenergic receptors. A role for beta-adrenergic receptor kinase.
J. Clin. Investig.
93:937-943.
|
| 8.
|
Haruta, T.,
A. J. Morris,
D. W. Rose,
J. G. Nelson,
M. Mueckler, and J. M. Olefsky.
1995.
Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway.
J. Biol. Chem.
270:27991-27994[Abstract/Free Full Text].
|
| 9.
|
Haruta, T.,
A. J. Morris,
P. Vollenweider,
J. G. Nelson,
D. W. Rose,
M. Mueckler, and J. M. Olefsky.
1998.
Ligand-independent GLUT4 translocation induced by guanosine 5'-O-(3-thiotriphosphate) involves tyrosine phosphorylation.
Endocrinology
139:358-364[Abstract/Free Full Text].
|
| 10.
|
Heximer, S. P.,
N. Watson,
M. E. Linder,
K. J. Blumer, and J. R. Hepler.
1997.
RGS2/G0S8 is a selective inhibitor of Gq alpha function.
Proc. Natl. Acad. Sci. USA
94:14389-14393[Abstract/Free Full Text].
|
| 11.
|
Imanaka, T.,
H. Hayashi,
K. Kishi,
L. Wang,
K. Ishii,
O. Hazeki,
T. Katada, and Y. Ebina.
1998.
Reconstitution of insulin signaling pathways in rat 3Y1 cells lacking insulin receptor and insulin receptor substrate-1. Evidence that activation of Akt is insufficient for insulin-stimulated glycogen synthesis or glucose uptake in rat 3Y1 cells.
J. Biol. Chem.
273:25347-25355[Abstract/Free Full Text].
|
| 12.
|
Kishi, K.,
M. Muromoto,
Y. Nakaya,
I. Miyata,
A. Hagi,
H. Hayashi, and I. Ebina.
1998.
Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
Diabetes
47:550-558[Abstract].
|
| 13.
|
Kishi, K.,
H. Hayashi,
L. Wang,
S. Kamohara,
K. Tamaoka,
T. Shimizu,
F. Ushikubi, and Y. Ebina.
1996.
Gq-coupled receptors transmit the signal for GLUT4 translocation via an insulin-independent pathway.
J. Biol. Chem.
271:26561-26568[Abstract/Free Full Text].
|
| 14.
|
Klip, A.,
G. Li, and W. J. Logan.
1984.
Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts.
Am. J. Physiol.
247:E291-E296[Abstract/Free Full Text].
|
| 15.
|
Kohn, A. D.,
S. A. Summers,
M. J. Birnbaum, and R. A. Roth.
1996.
Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation.
J. Biol. Chem.
271:31372-31378[Abstract/Free Full Text].
|
| 16.
|
Kotani, K.,
W. Ogawa,
M. Matsumoto,
T. Kitamura,
H. Sakaue,
Y. Hino,
K. Miyake,
W. Sano,
K. Akimoto,
S. Ohno, and M. Kasuga.
1999.
Requirement of atypical protein kinase c-lambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes.
Mol. Cell. Biol.
18:6971-6982[Abstract/Free Full Text].
|
| 17.
|
Nakashima, N.,
D. W. Rose,
S. Xiao,
K. Egawa,
S. S. Martin,
T. Haruta,
A. R. Saltiel, and J. M. Olefsky.
1999.
The functional role of CrkII in actin cytoskeleton organization and mitogenesis.
J. Biol. Chem.
274:3001-3008[Abstract/Free Full Text].
|
| 18.
|
Neer, E. J.
1995.
Heterotrimeric G proteins: organizers of transmembrane signals.
Cell
80:249-257[Medline].
|
| 19.
|
Okada, T.,
Y. Kawano,
T. Sakakibara,
O. Hazeki, and M. Ui.
1994.
Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.
J. Biol. Chem.
269:3563-3573[Abstract/Free Full Text].
|
| 20.
|
Robinson, L. J.,
S. Pang,
D. S. Harris,
J. Heuser, and D. E. James.
1992.
Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices.
J. Cell Biol.
117:1181-1196[Abstract/Free Full Text].
|
| 21.
|
Schieffer, B.,
W. G. Paxton,
Q. Chai,
M. B. Marrero, and K. E. Bernstein.
1996.
Angiotensin II controls p21ras activity via pp60c-src.
J. Biol. Chem.
271:10329-10333[Abstract/Free Full Text].
|
| 22.
|
Sharma, P. M.,
K. Egawa,
T. A. Gustafson,
J. L. Martin, and J. M. Olefsky.
1997.
Adenovirus-mediated overexpression of IRS-1 interacting domains abolishes insulin-stimulated mitogenesis without affecting glucose transport in 3T3-L1 adipocytes.
Mol. Cell. Biol.
17:7386-7397[Abstract].
|
| 23.
|
Staubs, P. A.,
J. G. Nelson,
D. R. Reichart, and J. M. Olefsky.
1998.
Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport.
J. Biol. Chem.
273:25139-25147[Abstract/Free Full Text].
|
| 24.
|
Umemori, H.,
T. Inoue,
S. Kume,
N. Sekiyama,
M. Nagao,
H. Itoh,
S. Nakanishi,
K. Mikoshiba, and T. Yamamoto.
1997.
Activation of the G protein Gq/11 through tyrosine phosphorylation of the alpha subunit.
Science
276:1878-1881[Abstract/Free Full Text].
|
| 25.
|
van Biesen, T.,
B. E. Hawes,
D. K. Luttrell,
K. M. Krueger,
K. Touhara,
E. Porfiri,
M. Sakaue,
L. M. Luttrell, and R. J. Lefkowitz.
1995.
Receptor-tyrosine-kinase and G beta gamma-mediated MAP kinase activation by a common signalling pathway.
Nature
376:781-784[Medline].
|
| 26.
|
Vollenweider, P.,
S. S. Martin,
T. Haruta,
A. J. Morris,
J. G. Nelson,
M. Cormont,
Y. L. Marchand-Brustel,
D. W. Rose, and J. M. Olefsky.
1997.
The small guanosine triphosphate-binding protein Rab4 is involved in insulin-induced GLUT4 translocation and actin filament rearrangement in 3T3-L1 cells.
Endocrinology
138:4941-4949[Abstract/Free Full Text].
|
| 27.
|
Wan, Y.,
T. Kurosaki, and X. Y. Huang.
1996.
Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors.
Nature
380:541-544[Medline].
|
Molecular and Cellular Biology, October 1999, p. 6765-6774, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.